7 | Type I DNA Topoisomerases (Topoisomerase I)IBA
06/2012
-
01/2010 |
5 | Antineoplastic Agents (Antineoplastics)IBA
01/2018
-
01/2010 |
4 | Anti-Inflammatory Agents (Anti-Inflammatories)IBA
05/2024
-
01/2023 |
3 | Therapeutic UsesIBA
05/2024
-
01/2016 |
3 | Cyclophilin AIBA
01/2022
-
12/2015 |
3 | Melanins (Melanin)IBA
01/2020
-
11/2011 |
3 | Phosphotransferases (Kinase)IBA
01/2017
-
11/2010 |
3 | Androgen Receptors (Androgen Receptor)IBA
12/2016
-
08/2012 |
2 | CytokinesIBA
04/2023
-
03/2023 |
2 | Antiviral Agents (Antivirals)IBA
07/2021
-
10/2020 |
2 | Proteins (Proteins, Gene)FDA Link
01/2020
-
01/2017 |
2 | Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2019
-
02/2008 |
2 | trioctyl phosphine oxide (TOPO)IBA
01/2018
-
01/2011 |
2 | AndrogensIBA
12/2016
-
08/2012 |
2 | PyridinesIBA
02/2012
-
05/2010 |
2 | pyridineIBA
03/2010
-
01/2010 |
1 | Dextran SulfateIBA
05/2024 |
1 | 4-hydroxycoumarinIBA
05/2024 |
1 | osthol (osthole)IBA
02/2024 |
1 | N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
01/2024 |
1 | AmidesIBA
11/2023 |
1 | SulfonamidesIBA
11/2023 |
1 | AcidsIBA
04/2023 |
1 | Lymphocyte Antigen 96IBA
04/2023 |
1 | diphenyl (biphenyl)IBA
01/2023 |
1 | IndolesIBA
01/2023 |
1 | hexosaminidase CIBA
08/2022 |
1 | tau Proteins (tau Protein)IBA
08/2022 |
1 | VaccinesIBA
07/2021 |
1 | Peptide Hydrolases (Proteases)FDA Link
10/2020 |
1 | Stem Cell FactorIBA
01/2020 |
1 | Messenger RNA (mRNA)IBA
01/2020 |
1 | 7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA
11/2019 |
1 | Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
11/2019 |
1 | PoisonsIBA
01/2018 |
1 | Toll-Like Receptors (Toll-Like Receptor)IBA
11/2017 |
1 | Myeloid Differentiation Factor 88IBA
11/2017 |
1 | Toll-Like Receptor AgonistsIBA
01/2017 |
1 | GalactosamineIBA
01/2017 |
1 | Toll-Like Receptor 4IBA
01/2017 |
1 | LipopolysaccharidesIBA
01/2017 |
1 | caffeic acidIBA
01/2017 |
1 | Poly (ADP-Ribose) Polymerase-1IBA
12/2016 |
1 | Alanine (L-Alanine)FDA Link
12/2016 |
1 | Niacinamide (Nicotinamide)FDA LinkGeneric
12/2016 |
1 | Proline (L-Proline)FDA Link
12/2016 |
1 | Prostate-Specific Antigen (Semenogelase)IBA
12/2016 |
1 | Selenoprotein PIBA
12/2016 |
1 | Caspase 3 (Caspase-3)IBA
12/2016 |
1 | Tyrosine Kinase InhibitorsIBA
11/2016 |
1 | EnzymesIBA
01/2016 |
1 | BerberineIBA
01/2016 |
1 | Melanocyte-Stimulating Hormones (MSH)IBA
07/2015 |
1 | Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
07/2015 |
1 | diphenylmethylene hydrazinecarbothioamideIBA
07/2015 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
07/2014 |
1 | Etoposide (VP 16)FDA LinkGeneric
07/2014 |
1 | CamptothecinIBA
07/2014 |
1 | 2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
07/2014 |
1 | LigandsIBA
08/2013 |
1 | daidzeinIBA
08/2013 |
1 | RetinoidsIBA
08/2013 |
1 | TubulinIBA
08/2013 |
1 | Androgen Receptor AntagonistsIBA
04/2013 |